0001415889-23-013115.txt : 20230908
0001415889-23-013115.hdr.sgml : 20230908
20230908160011
ACCESSION NUMBER: 0001415889-23-013115
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230907
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LILLY ENDOWMENT INC
CENTRAL INDEX KEY: 0000316011
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06351
FILM NUMBER: 231245224
BUSINESS ADDRESS:
STREET 1: 2801 NORTH MERIDIAN STREET
CITY: INDIANANAPOLIS
STATE: IN
ZIP: 46208
BUSINESS PHONE: 3179245471
MAIL ADDRESS:
STREET 1: 2801 NORTH MERIDIAN ST
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELI LILLY & Co
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 350470950
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
FORMER COMPANY:
FORMER CONFORMED NAME: LILLY ELI & CO
DATE OF NAME CHANGE: 19941024
4
1
form4-09082023_040901.xml
X0508
4
2023-09-07
0000059478
ELI LILLY & Co
LLY
0000316011
LILLY ENDOWMENT INC
2801 NORTH MERIDIAN STREET
INDIANAPOLIS
IN
46208-0068
false
false
true
false
0
Common Stock
2023-09-07
4
S
0
4200
565.136
D
100189610
D
Common Stock
2023-09-07
4
S
0
7732
566.063
D
100181878
D
Common Stock
2023-09-07
4
S
0
7382
567.185
D
100174496
D
Common Stock
2023-09-07
4
S
0
14978
568.093
D
100159518
D
Common Stock
2023-09-07
4
S
0
15258
568.894
D
100144260
D
Common Stock
2023-09-07
4
S
0
10412
570.047
D
100133848
D
Common Stock
2023-09-07
4
S
0
27849
571.656
D
100105999
D
Common Stock
2023-09-07
4
S
0
60926
572.357
D
100045073
D
Common Stock
2023-09-07
4
S
0
46428
573.335
D
99998645
D
Common Stock
2023-09-07
4
S
0
11335
574.28
D
99987310
D
Common Stock
2023-09-07
4
S
0
3500
575.372
D
99983810
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.50 to $565.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), and (11) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.53 to $566.525, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $566.53 to $567.495, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $567.55 to $568.54, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $568.55 to $569.35, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $569.58 to $570.57, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.89 to $571.885, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.89 to $572.88, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.89 to $573.88, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.89 to $574.86, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.90 to $575.88, inclusive.
/s/ Diane M. Stenson, Vice President & Treasurer, on behalf of Lilly Endowment Inc.
2023-09-08